홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Diisopropylethylamine → 2-bromo-N-[4-methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-yl]-isonicotinamide

HRID 1582164
노트
인쇄 미리보기

반응식

HRID 1582164 반응식
[Br:1][C:2]1[CH:3]=[C:4]([CH:8]=[CH:9][N:10]=1)[C:5]([OH:7])=O.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(C(C)C)C(C)C)C.[CH3:44][O:45][C:46]1[C:51]2[N:52]=[C:53]([NH2:55])[S:54][C:50]=2[C:49]([CH:56]2[CH2:61][CH2:60][CH2:59][CH2:58][O:57]2)=[CH:48][CH:47]=1.C(=O)(O)[O-].[Na+]>C1COCC1.O1CCOCC1.CN(C=O)C>[Br:1][C:2]1[CH:3]=[C:4]([CH:8]=[CH:9][N:10]=1)[C:5]([NH:55][C:53]1[S:54][C:50]2[C:49]([CH:56]3[CH2:61][CH2:60][CH2:59][CH2:58][O:57]3)=[CH:48][CH:47]=[C:46]([O:45][CH3:44])[C:51]=2[N:52]=1)=[O:7]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 5

HCID 81531DiisopropylethylamineHCID 2227012-Bromoisonicotinic acidHCID 516892Sodium BicarbonateHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 227195344-Methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-ylamine

생성물 1

HCID 10310452
2-bromo-N-[4-methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-yl]-isonicotinamide
수율 29.5%

시약·촉매·용매 3

HCID 6228Dimethylformamide용매HCID 8028Tetrahydrofuran용매HCID 312751,4-Dioxane용매

실험 절차

To a stirred solution of 0.99 g (4.92 mmol) 2-bromo-isonicotinic acid in 40 ml THF were added 2.16 g (5.67 mmol) HATU and 0.97 ml (5.67 mmol) N-ethyldiisopropylamine and stirring continued at room temperature for 1 h. A solution of 1.00 g (3.78 mmol) 4-methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-ylamine in 20 ml dioxane and 4 ml DMF was then added and stirring continued at room temperature for 48 h. The reaction mixture was then poured into aqueous sodium bicarbonate solution and extracted three times with dichloromethane. The combined organic phases were washed with 1 M hydrochloric acid, then dried over sodium sulfate and concentrated in vacuo. Flash chromatography (acetone/hexane 1/4) followed by trituration in ether afforded 500 mg (29%) 2-bromo-N-[4-methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-yl]-isonicotinamide as a light yellow crystalline solid. ES-MS m/e (%): 450 (M{81Br}+H+, 100), 448 (M{79Br}+H+, 80).

후처리

  1. stirringstirring
  2. waitcontinued at room temperature for 48 h
  3. extractionextracted three times with dichloromethane
  4. washThe combined organic phases were washed with 1 M hydrochloric acid
  5. dry with materialdried over sodium sulfate
  6. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-23fe45ec78f048dc8a93fe2e5c26eda9
출처 데이터셋
uspto-grants-2004_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06734179B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트